miRNA-148b-3p Influences Glucose Metabolism of Offspring with Maternal Cholestasis by Regulating GLUT1 Expression in Placental Trophoblast Cells

JING Xiao-lin; XING Ai-yun; BAI Huai; WU Lin

Volume 50 Issue 3

May 2019

Turn off MathJax

Article Contents

Abstract

References

JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) > 2019 > 50(3): 328-333.

JING Xiao-lin, XING Ai-yun, BAI Huai, et al. miRNA-148b-3p Influences Glucose Metabolism of Offspring with Maternal Cholestasis by Regulating GLUT1 Expression in Placental Trophoblast Cells[J]. Journal of Sichuan University (Medical Sciences), 2019, 50(3): 328-333.

Citation:

PDF (617 KB)

miRNA-148b-3p Influences Glucose Metabolism of Offspring with Maternal Cholestasis by Regulating GLUT1 Expression in Placental Trophoblast Cells

JING Xiao-lin^{1, 2},
XING Ai-yun^{1, 2},
BAI Huai^{1, 2},
WU Lin^{1, 2, ,}

1.
Laboratory of Genetic Disease and Perinatal Medicine, West China Second University Hospital, Sichuan University; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China
2.
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China

More Information

Corresponding author:
WU Lin, E-mail: jadeitewl@163.com
Received Date: October 09, 2018
Revised Date: January 14, 2019
Available Online: October 28, 2019
Published Date: May 19, 2019

Abstract

Abstract

Objective To investigate the expression of miRNA-148b-3p and its target gene in the placenta between normal pregnant women and pregnant women with intrahepatic cholestasis of pregnancy (ICP) and to explore the possible mechanism of glucose metabolism of offspring with maternal cholestasis.
Methods There were 30 cases of normal pregnant women and 30 cases of pregnant women with ICP recruited in the study, all of whom underwent cesarean delivery from Mar. 2017 to Jan. 2018. Placenta tissues, maternal blood and cord blood were collected in each case. Maternal blood and cord blood were sent for biochemical detection. miRNA of placenta tissues was extracted and qRT-PCR was used to measure the expression of miR-148b-3p in the placenta. Normal HTR-8 cells were transfected with miR-148b-3p inhibitor/mimics wrapped with lipofectaine3000. qRT-PCR was used to measure the expression of miR-148b-3p, and Western blot was used to measure the expression of glucose transporter 1 (GLUT1) after transfection.
Results Maternal fasting blood glucose (FPG) and its fetal cord blood insulin levels in the ICP group were significantly higher than those of control. The expression of miR-148b-3p in the placenta of ICP group was lower than that of control group (P<0.05). Compared with inhibitor control group, the expression of miR-148b-3p was decreased in HTR-8 cells transfected with miR-148b-3p inhibitor (P<0.05), while the expression of GLUT1 was increased (P<0.05). Compared with mimics control group, the expression of miR-148b-3p was increased in HTR-8 cells transfected with miR-148b-3p mimics (P<0.05), while the expression of GLUT1 was decreased (P<0.05).
Conclusion miR-148b-3p might participate in glucose metabolism of offspring with maternal cholestasis through the negative regulation of GLUT1 expression in placental trophoblast cells.
- ICP,
- miRNA,
- miRNA-148b-3p,
- GLUT1,
- qRT-PCR,
- Western blot

FullText(HTML)

References (34)

References

[1]	WILLIAMSON C, GEENES V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol,2014,124(1): 120–133. DOI: 10.1097/AOG.0000000000000346
[2]	WIKSTRÖM SHEMER E, MARSCHALL HU, LUDVIGSSON JF, et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study editorial comment. BJOG,2013,120(6): 717–723. DOI: 10.1111/1471-0528.12174
[3]	KENYON AP, PIERCY CN, GIRLING J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG,2002,109(3): 282–288. DOI: 10.1111/j.1471-0528.2002.01368.x
[4]	REZAI S, LAM J, HENDERSON CE. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol, 2015, 213(1): 114[2018-11-14]. https://doi.org/10.1016/j.ajog.2015.03.040.
[5]	MARTINEAU MG, RAKER C, DIXON PH, et al. The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care,2015,38(2): 243–248. DOI: 10.2337/dc14-2143
[6]	MARTINEAU M, RAKER C, POWRIE R, et al. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol, 2014, 176: 80-85[2018-11-14]. https://doi.org/10.1016/j.ejogrb.2013.12.037.
[7]	PAPACLEOVOULOU G, ABU-HAYYEH S, NIKOLOPOULOU E, et al. Maternal cholestasis during pregnancy programs metabolic disease in offspring. J Clin Invest,2013,123(7): 3172–3181. DOI: 10.1172/JCI68927
[8]	BAUMANN MU, DEBORDE S, ILLSLEY NP. Placental glucose transfer and fetal growth. Endocrine,2002,19(1): 13–22. DOI: 10.1385/ENDO:19:1
[9]	ACOSTA O, RAMIREZ VI, LAGER S, et al. Increased glucose and placental GLUT-1 in large infants of obese nondiabetic mothers. Am J Obstet Gynecol, 2015, 212(2): 227. e1-e7[2018-11-14]. https://doi.org/10.1016/j.ajog.2014.08.009.
[10]	WEI W, HU YY. Expression of hypoxia-regulated genes and glycometabolic genes in placenta from patients with intrahepatic cholestasis of pregnancy. Placenta,2014,35(9): 732–736. DOI: 10.1016/j.placenta.2014.06.372
[11]	ALVAREZ-GARCIA I, MISKA EA. MicroRNA functions in animal development and human disease. Development,2005,132(21): 4653–4662. DOI: 10.1242/dev.02073
[12]	KROL J, LOEDIGE I, FILIPOWICZ W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet,2010,11(9): 597–610. DOI: 10.1038/nrg2843
[13]	贺晶, 杨慧霞, 段涛, 等. 妊娠期肝内胆汁淤积症诊疗指南(2015). 临床肝胆病杂志,2015,31(10): 1575–1578. DOI: 10.3969/j.issn.1001-5256.2015.10.003
[14]	ILLSLEY NP. Glucose transporters in the human placenta. Placenta,2000,21(1): 14–22. DOI: 10.1053/plac.1999.0448
[15]	BARTA E, DRUGAN A. A clinical study which relates to a theoretical simulation of the glucose transport in the human placenta under various diabetic conditions. J Perinat Med,2016,44(4): 405–410.
[16]	BAUMANN MU, ZAMUDIO S, ILLSLEY NP. Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am J Physiol Cell Physiol,2007,293(1): C477–C485. DOI: 10.1152/ajpcell.00075.2007
[17]	JANSSON T, EKSTRAND Y, WENNERGREN M, et al. Placental glucose transport in gestational diabetes mellitus. Am J Obstet Gynecol,2001,184(2): 111–116. DOI: 10.1067/mob.2001.108075
[18]	SHI Z, ZHAO C, GUO X, et al. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERalpha expression in estrogen-induced insulin resistance. Endocrinology,2014,155(5): 1982–1990. DOI: 10.1210/en.2013-2046
[19]	RAO ZZ, ZHANG XW, DING YL, et al. miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: role of PXR/MRP3. PLoS One, 2017, 12(6): e0178702[2018-11-20]. https://doi.org/10.1371/journal.pone.0178702.
[20]	MOUILLET JF, OUYANG Y, COYNE CB, et al. MicroRNAs in placental health and disease. Am J Obstet Gynecol,2015,213(4 Suppl): S163–S172.
[21]	POIRIER C, DESGAGNE V, GUERIN R, et al. MicroRNAs in pregnancy and gestational diabetes mellitus: emerging role in maternal metabolic regulation. Curr Diab Rep,2017,17(5): 35. DOI: 10.1007/s11892-017-0856-5
[22]	MAVRELI D, PAPANTONIOU N, KOLIALEXI A. miRNAs in pregnancy-related complications: an update. Expert Rev Mol Diagns,2018,18(7): 587–589. DOI: 10.1080/14737159.2018.1480939
[23]	CHEN Y, SONG YX, WANG ZN. The microRNA-148/152 family: multi-faceted players. Mol Cancer,2013,12: 43. DOI: 10.1186/1476-4598-12-43
[24]	MIAO C, ZHANG J, ZHAO K, et al. The significance of microRNA-148/152 family as a prognostic factor in multiple human malignancies: a meta-analysis. Oncotarget,2017,8(26): 43344–43355.
[25]	ZHANG H, YE Q, DU Z, et al. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2. Biomed Pharmacother, 2018, 107: 359-367[2018-11-20]. https://doi.org/10.1016/j.biopha.2018.07.054.
[26]	WANG Y, LI J, KUANG D, et al. miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT. Cell Commun Signal,2018,16(1): 16. DOI: 10.1186/s12964-018-0228-z
[27]	LI X, JIANG M, CHEN D, et al. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. J Exp Clin Cancer Res,2018,37(1): 71. DOI: 10.1186/s13046-018-0729-z
[28]	DING X, LIU J, LIU T, et al. miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer Med,2017,6(6): 1301–1310. DOI: 10.1002/cam4.2017.6.issue-6
[29]	AGARWAL V, BELL GW, NAM JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife, 2015, 4: e05005[2018-11-20]. https://doi.org/10.7554/eLife.05005.001.
[30]	BARKER DJ. The origins of the developmental origins theory. J Intern Med,2007,261(5): 412–417. DOI: 10.1111/jim.2007.261.issue-5
[31]	SILVEIRA PP, PORTELLA AK, GOLDANI MZ, et al. Developmental origins of health and disease (DOHaD). J Pediatr (Rio J),2007,83(6): 494–504. DOI: 10.2223/JPED.1728
[32]	MEAS T. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?. Diabetes Metab,2010,36(1): 11–20. DOI: 10.1016/j.diabet.2009.09.001
[33]	KANAKA-GANTENBEIN C. Fetal origins of adult diabetes. Ann N Y Acad Sci,2010,1205: 99–105. DOI: 10.1111/j.1749-6632.2010.05683.x
[34]	HANSON MA, GLUCKMAN PD. Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol,2008,102(2): 90–93. DOI: 10.1111/j.1742-7843.2007.00186.x

Relative Articles

Supplements (0)

Cited By

Get Citation

PDF

XML

Article views (1719) PDF downloads (33)

miRNA-148b-3p Influences Glucose Metabolism of Offspring with Maternal Cholestasis by Regulating GLUT1 Expression in Placental Trophoblast Cells

Abstract

References

Catalog

Export File

Citation

Format

Content